TRAW

NASDAQ · Pharmaceuticals

Traws Pharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.15

-0.07 (-3.15%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +934.4% upside

Low Target $15.33

Average Target $22.24

High Target $34.90

Current Price $2.15

Current
$2.15

Target
$22.24

$15.33 $22.24 avg $34.90

Scenario Analysis

Bear Case

$15.33

613.0%

Low target

Base Case

$22.24

+934.4%

Avg target

Bull Case

$34.90

+1,523.3%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$3.27

-34.2% from high

52-Week Low

$0.97

+121.6% from low

Target vs 52W High

$22.24

+581.2% vs high

Next Earnings Report

Mar 30, 2026 · After Market Close

until earnings

EPS Est: $-1.25

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%